SB 0929 - Fiscal Note

Fiscal Note - SB 0929 - Outlaws the Sale of Ephedrine

L.R. NO.  3489-01
BILL NO.  Truly Agreed and Finally Passed SB 929
SUBJECT:  Drugs and Controlled Substances:  Pharmacy
TYPE:     Original
DATE:     April 17, 1996



                              FISCAL SUMMARY
                    ESTIMATED NET EFFECT ON STATE FUNDS


FUND AFFECTED              FY 1997             FY 1998           FY 1999

NONE

Total Estimated
Net Effect on All
State Funds                     $0                  $0                $0


                   ESTIMATED NET EFFECT ON FEDERAL FUNDS


FUND AFFECTED              FY 1997             FY 1998           FY 1999

NONE

Total Estimated
Net Effect on All
Federal Funds                   $0                  $0                $0


                    ESTIMATED NET EFFECT ON LOCAL FUNDS


FUND AFFECTED              FY 1997             FY 1998           FY 1999

Local Government                $0                  $0                $0


                              FISCAL ANALYSIS

ASSUMPTION

Officials from the Department of Health, the Office of State Courts
Administrator, the State Public Defender, and the Department of Corrections
assume this proposal would not fiscally impact their agencies.

Office of Prosecution Services officials assume this proposal would have
minimal impact upon their agency.


FISCAL IMPACT - State Government   FY 1997   FY 1998   FY 1999
                                  (10 Mo.)

                                        $0        $0        $0


FISCAL IMPACT  - Local Government  FY 1997   FY 1998   FY 1999
                                  (10 Mo.)

                                        $0        $0        $0

DESCRIPTION

This proposal would make it unlawful to possess ephedrine or its derivatives
with the intent to manufacture methamphetamine.  It addition, this proposal
would make it unlawful to market, sell, distribute, advertise or label any
drug product containing ephedrine for indication of stimulation, mental
alertness, weight loss, appetite control, energy or other indications not
approved by the federal over-the-counter drug Final Monograph or Tentative
Final Monograph or approved new drug application.  Those who would violate
these provisions are guilty of a Class A misdemeanor.   This legislation is
not federally mandated, would not duplicate any other program and would not
require additional capital improvements or rental space.


SOURCES OF INFORMATION

Department of Health
Office of State Courts Administrator
Office of Prosecution Services
State Public Defender
Department of Corrections